Investigators considered patients prescribed MM from May 2016 to February 2019 and reviewed the formulation prescribed, usage patterns, length of use, symptom relief and side effects.
“In cancer patients with inadequately controlled pain on opioids, the addition of THC:CBD containing compounds and nabiximols improves pain scores compared to placebo in some, but not all studies,” the authors note.
We have enabled email notifications—you will now receive an email if you receive a reply to your comment, there is an update to a comment thread you follow or if a user you follow comments.
This website uses cookies to personalize your content , and allows us to analyze our traffic.